Judith Stift

3.1k total citations
73 papers, 1.9k citations indexed

About

Judith Stift is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Judith Stift has authored 73 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hepatology, 33 papers in Epidemiology and 29 papers in Oncology. Recurrent topics in Judith Stift's work include Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Liver Disease and Transplantation (13 papers). Judith Stift is often cited by papers focused on Liver Disease Diagnosis and Treatment (27 papers), Hepatocellular Carcinoma Treatment and Prognosis (14 papers) and Liver Disease and Transplantation (13 papers). Judith Stift collaborates with scholars based in Austria, United States and Germany. Judith Stift's co-authors include Michael Trauner, Thomas Reiberger, Ahmed Ba‐Ssalamah, Nina Bastati, Friedrich Wrba, Philipp Schwabl, Stefan Stremitzer, Thomas Gruenberger, Matthias Pinter and Diana Feier and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Judith Stift

68 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Judith Stift Austria	27	917	837	534	319	272	73	1.9k
Delia D’Avola Spain	25	1.2k 1.3×	726 0.9×	407 0.8×	489 1.5×	326 1.2×	60	2.1k
Patrick Starlinger Austria	26	701 0.8×	566 0.7×	529 1.0×	511 1.6×	183 0.7×	129	1.7k
Aya Miyagawa‐Hayashino Japan	25	873 1.0×	588 0.7×	415 0.8×	915 2.9×	342 1.3×	90	2.1k
Kazuki Takeishi Japan	28	1.2k 1.3×	729 0.9×	742 1.4×	848 2.7×	278 1.0×	108	2.4k
Koji Uchino Japan	15	1.1k 1.2×	802 1.0×	434 0.8×	491 1.5×	272 1.0×	43	1.9k
Marta I. Minervini United States	22	640 0.7×	543 0.6×	294 0.6×	616 1.9×	214 0.8×	63	1.7k
Tomokazu Kawaoka Japan	25	1.6k 1.7×	1.2k 1.4×	281 0.5×	352 1.1×	219 0.8×	150	2.1k
Anna Skowrońska United Kingdom	13	1.5k 1.7×	1.1k 1.4×	724 1.4×	424 1.3×	302 1.1×	37	2.6k
Hirotaka Tashiro Japan	26	1.5k 1.6×	860 1.0×	432 0.8×	1.1k 3.5×	310 1.1×	214	2.6k
Panagiotis Samaras Switzerland	23	418 0.5×	389 0.5×	655 1.2×	280 0.9×	312 1.1×	71	1.9k

Countries citing papers authored by Judith Stift

Since Specialization

Citations

This map shows the geographic impact of Judith Stift's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Judith Stift with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Judith Stift more than expected).

Fields of papers citing papers by Judith Stift

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Judith Stift. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Judith Stift. The network helps show where Judith Stift may publish in the future.

Co-authorship network of co-authors of Judith Stift

This figure shows the co-authorship network connecting the top 25 collaborators of Judith Stift. A scholar is included among the top collaborators of Judith Stift based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Judith Stift. Judith Stift is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Santol, Jonas, Birgit Gruenberger, A. Lenauer, et al.. (2024). Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers. 16(5). 857–857. 1 indexed citations

Starlinger, Patrick, David Pereyra, Judith Stift, et al.. (2023). Tyrosine phosphorylation of YAP‐1 in biliary epithelial cells mediates posthepatectomy liver regeneration and is affected by serotonin. Journal of Cellular Biochemistry. 124(5). 687–700. 1 indexed citations

Paliwal, Sumit, Jaime Martínez de Villarreal, Rupert Öllinger, et al.. (2021). A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer. Gut. 71(4). 766–777. 47 indexed citations

Rohr‐Udilova, Nataliya, Kaoru Tsuchiya, Gerald Timelthaler, et al.. (2021). Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Hepatology Communications. 5(11). 1939–1952. 9 indexed citations

Brusilovskaya, Ksenia, Philipp Königshofer, David Bauer, et al.. (2020). Soluble guanylyl cyclase stimulation and phosphodiesterase‐5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct–ligated rats. United European Gastroenterology Journal. 8(10). 1174–1185. 26 indexed citations

Semmler, Georg, Katharina Wöran, Bernhard Scheiner, et al.. (2020). Novel reliability criteria for controlled attenuation parameter assessments for non‐invasive evaluation of hepatic steatosis. United European Gastroenterology Journal. 8(3). 321–331. 38 indexed citations

Stremitzer, Stefan, Peter Vermeulen, Mark Kockx, et al.. (2020). Immune phenotype and histopathological growth pattern in patients with colorectal liver metastases. British Journal of Cancer. 122(10). 1518–1524. 31 indexed citations

Staufer, Katharina, Emina Halilbasic, Walter Spindelboeck, et al.. (2019). Evaluation and comparison of six noninvasive tests for prediction of significant or advanced fibrosis in nonalcoholic fatty liver disease. United European Gastroenterology Journal. 7(8). 1113–1123. 64 indexed citations

Pereyra, David, Dietmar Tamandl, Judith Stift, et al.. (2019). The Combination of APRI and ALBI Facilitates Preoperative Risk Stratification for Patients Undergoing Liver Surgery After Neoadjuvant Chemotherapy. Annals of Surgical Oncology. 26(3). 791–799. 26 indexed citations

10.

Saghafi, Saiedeh, Klaus Becker, Christian Hahn, et al.. (2018). Reshaping a multimode laser beam into a constructed Gaussian beam for generating a thin light sheet. Journal of Biophotonics. 11(6). e201700213–e201700213. 5 indexed citations

11.

Rohr‐Udilova, Nataliya, Florian Klinglmüller, Rolf Schulte‐Hermann, et al.. (2018). Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Scientific Reports. 8(1). 6220–6220. 130 indexed citations

12.

Traussnigg, Stefan, Christian Kienbacher, Martin Gajdošík, et al.. (2017). Ultra‐high‐field magnetic resonance spectroscopy in non‐alcoholic fatty liver disease: Novel mechanistic and diagnostic insights of energy metabolism in non‐alcoholic steatohepatitis and advanced fibrosis. Liver International. 37(10). 1544–1553. 36 indexed citations

13.

Stremitzer, Stefan, Wu Zhang, Dongyun Yang, et al.. (2016). Expression of Genes Involved in Vascular Morphogenesis and Maturation Predicts Efficacy of Bevacizumab-Based Chemotherapy in Patients Undergoing Liver Resection. Molecular Cancer Therapeutics. 15(11). 2814–2821. 8 indexed citations

14.

Schauer, Dominic, Patrick Starlinger, Thomas Maier, et al.. (2016). Chemotherapy of colorectal liver metastases induces a rapid rise in intermediate blood monocytes which predicts treatment response. OncoImmunology. 5(6). e1160185–e1160185. 13 indexed citations

15.

Ba‐Ssalamah, Ahmed, Diana Feier, Nina Bastati, et al.. (2015). Morphologic and Molecular Features of Hepatocellular Adenoma with Gadoxetic Acid–enhanced MR Imaging. Radiology. 277(1). 104–113. 95 indexed citations

16.

Stremitzer, Stefan, Judith Stift, Jagdeep Singh, et al.. (2015). Histological response, pattern of tumor destruction and clinical outcome after neoadjuvant chemotherapy including bevacizumab or cetuximab in patients undergoing liver resection for colorectal liver metastases. European Journal of Surgical Oncology. 41(7). 868–874. 21 indexed citations

17.

Stättermayer, Albert Friedrich, Stefan Traussnigg, Hans‐Peter Dienes, et al.. (2015). Hepatic steatosis in Wilson disease – Role of copper and PNPLA3 mutations. Journal of Hepatology. 63(1). 156–163. 73 indexed citations

18.

Schwameis, Katrin, Sebastian F. Schoppmann, Judith Stift, Michael Schwameis, & Anton Stift. (2014). Small bowel adenocarcinoma - terra incognita: A demand for cross-national pooling of data. Oncology Letters. 7(5). 1613–1617. 10 indexed citations

19.

Schwabl, Philipp, B.A. Payer, Jelena Grahovac, et al.. (2014). Pioglitazone decreases portosystemic shunting by modulating inflammation and angiogenesis in cirrhotic and non-cirrhotic portal hypertensive rats. Journal of Hepatology. 60(6). 1135–1142. 37 indexed citations

20.

Montesinos‐Rongen, Manuel, Maren Weferling, Uta Drebber, et al.. (2012). Keratin 8 variants are associated with cryptogenic hepatitis. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 460(4). 389–397. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact